Markets:

Overview

News

Currencies

International

Treasuries

LeMaitre Vascular, Inc. - Common Stock (NQ:LMAT)

112.36 +1.61 (+1.45%)

Streaming Delayed Price Updated: 10:26 AM EDT, Mar 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about LeMaitre Vascular, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Recap: LeMaitre Vascular Q4 Earnings ↗

February 24, 2022

LeMaitre Vascular (NASDAQ:LMAT) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:05 PM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

6 Overlooked Dividend Stocks For Your Buy List ↗

December 18, 2021

A discussion about 6 dividend stocks that no one talks about.

Via Talk Markets

Why You Should Consider Buying This Little-Known Medical Devices Stock ↗

November 23, 2021

LeMaitre Vascular is a small-cap medical devices maker with the potential to continue growing rapidly in the years ahead.

Via The Motley Fool

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 29, 2021

Gainers MiNK Therapeutics (NASDAQ:INKT) shares rose 16.88% to $16.96 during Friday's regular session. Vocera Communications (NYSE:VCRA) shares increased by 12.13% to $...

Via Benzinga

The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs ↗

October 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc...

Via Benzinga

Lemaitre Vascular Inc (LMAT) Q3 2021 Earnings Call Transcript ↗

October 29, 2021

LMAT earnings call for the period ending August 31, 2021.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 28, 2021

Gainers Bellerophon Therapeutics (NASDAQ:

Via Benzinga

Recap: LeMaitre Vascular Q3 Earnings ↗

October 28, 2021

LeMaitre Vascular (NASDAQ:LMAT) reported its Q3 earnings results on Thursday, October 28, 2021 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug ↗

October 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021 ↗

September 16, 2021

Upgrades For Signet Jewelers Ltd (NYSE:

Via Benzinga

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Is This Under-the-Radar Medical Device Company a Post-Earnings Buy? ↗

August 06, 2021

LeMaitre Vascular's operating fundamentals and balance sheet suggest it's a buy, depending on your objectives.

Via The Motley Fool

Lemaitre Vascular Inc (LMAT) Q2 2021 Earnings Call Transcript ↗

July 30, 2021

LMAT earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

55 Biggest Movers From Yesterday ↗

July 15, 2021

Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares gained 37.6% to settle at $13.20 on Wednesday. SGOCO Group regained compliance with Nasdaq's listing standards on July 12 by...

Via Benzinga

34 Stocks Moving In Wednesday's Mid-Day Session ↗

July 14, 2021

Gainers Datasea Inc. (NASDAQ: DTSS) climbed 85% to $5.42. Datasea’s subsidiary Shuhai Zhangxun Information Technology Co., Ltd inked six purchase and distribution...

Via Benzinga

The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues ↗

July 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical...

Via Benzinga

LeMaitre Vascular Sees Better Than Expected Q2 Sales, Raises $55M Via Equity At 9% Discount ↗

July 14, 2021

LeMaitre Vascular Inc (NASDAQ: LMAT) has announced preliminary Q2 2021 results and sees net sales of $40.7 million compared to an estimated $37.9 million, up 64%Y/...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 13, 2021

Gainers scPharmaceuticals (NASDAQ:SCPH) ...

Via Benzinga

Should Investors Consider This Expanding Healthcare Business After Its Massive Dividend Hike? ↗

July 12, 2021

Did LeMaitre Vascular jeopardize its payout with its recent 16% dividend lift?

Via The Motley Fool

Glaukos Stock Sees Its Relative Strength Rating Improve To Key Above-80 Level ↗

July 01, 2021

Glaukos stock had its Relative Strength (RS) Rating upgraded from 78 to 81 Thursday. Is Glaukos on your watchlist?

Via Investor's Business Daily

The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs ↗

June 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal ↗

June 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme ↗

June 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,...

Via Benzinga

Stocks That Hit 52-Week Highs On Monday ↗

June 21, 2021

Monday's morning session saw 49 companies set new 52-week highs. Intriguing Points: The largest company by market cap to hit a new 52-week high was Shopify (...

Via Benzinga

The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗

June 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...

Via Benzinga

Edwards Lifesciences Stock Gets Revived With Relative Strength Rating Upgrade ↗

June 15, 2021

The Relative Strength (RS) Rating for Edwards Lifesciences stock headed into a higher percentile Tuesday, as it got a lift from 67 to 71.

Via Investor's Business Daily

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗

June 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

Analyzing LeMaitre Vascular's Ex-Dividend Date ↗

May 17, 2021

LeMaitre Vascular (NASDAQ:LMAT) declared a dividend payable on June 3, 2021 to its shareholders as of April 27, 2021. It was also announced that shareholders of LeMaitre Vascular'...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.